{"id":268653,"date":"2018-09-24T22:07:04","date_gmt":"2018-09-24T22:07:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=268653"},"modified":"2018-09-24T22:07:04","modified_gmt":"2018-09-24T22:07:04","slug":"vulvar-cancer-market-significant-trend-in-pharmaceutical-industry-with-by-key-types-adenocarcinoma-squamous-cell-carcinomas-melanoma-sarcoma-insights-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/vulvar-cancer-market-significant-trend-in-pharmaceutical-industry-with-by-key-types-adenocarcinoma-squamous-cell-carcinomas-melanoma-sarcoma-insights-2023_268653.html","title":{"rendered":"Vulvar Cancer Market Significant Trend in Pharmaceutical Industry with by Key Types Adenocarcinoma, Squamous Cell Carcinomas, Melanoma, Sarcoma \u2013 Insights 2023"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Market Research Future”<\/div>\n<\/div>\n<\/div>\n
\u201cVulvar Cancer Market\u201d Complete Universal Study on MarketResearchFuture.com Overview of Key Players and their Strategic Profiling in the Market, Comprehensively Analyzing their Core Competencies, and Drawing a Competitive Landscape for the Market.<\/div>\n

Global Vulvar Cancer Market – Scenario<\/strong><\/p>\n

Vulvar cancer is a rare disease that comprises of a malignant and invasive growth in the vulva. Being a rare disease it accounts for only 0.6- 0.7 % of total cancer diagnosis. Labia majora is the common site of this cancer as compared to labia minora.<\/p>\n

The major driving factor for this market is increasing prevalence of different types of like vulvar and vaginal cancer and changing lifestyle which is responsible for causing this cancer. On other hand high price associated with this disease and number of adverse effect of treatment may hamper the growth of this market. Global vulvar cancer market is expected to grow at a CAGR of 5.8% during forecasted period of 2017-2023.<\/p>\n

You Can Get Easy Access to Samples from the Report Here: @ <\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/1423<\/a><\/p>\n

Global Vulvar Cancer Market – Key Players<\/strong><\/p>\n

This market has various players, some of the key players in this market are Abbott Diagnostics (US), Ono pharmaceutical co ltd (Japan),PDS Biotechnology Corporation (US),Becton Deckinson and Company (US), Siemens Healthcare (Germany), Qiagen (Germany), ISA Pharmaceuticals B.V. (Netherland), ORYX GmbH & Co. KG (Germany), PfizerInc(US),AmgenInc.(US), Johnson & Johnson (US), Novartis AG (Switzerland),F. Hoffmann-La Roche Ltd (Switzerland) and Celgene Corporation (US), Merck&Co.(US).<\/p>\n

Global Vulvar Cancer Market – Segmentation <\/strong><\/p>\n

Global vulvar cancer market is segmented on the basis of types which includes adenocarcinoma, squamous cell carcinomas, melanoma, sarcoma and other. On the basis of treatment the market is segmented into radiation therapy, chemotherapy, surgery and drugs treatment.<\/p>\n

Surgery is further sub segmented into excision, radical vulvectomy, partial vulvectomy and other. On the basis of end user it is segmented into hospitals, clinics, and cancer research institutes and other<\/p>\n

On application, chemotherapy is the most preferred treatment for vulvar cancer. However, due to side effects this segment may have slow growth and its position will be taken by surgical treatment.<\/p>\n

Global Vulvar Cancer Market<\/a> – Competitive Analysis<\/strong><\/p>\n

Due to increasing prevalence of vulvar cancer, globally many companies are in the race of inventing better treatment for vulvar cancer. Companies are using a trend of strategic alliance and acquisition to gain a high position in the market and minimize competition in the market.<\/p>\n

Ono pharmaceutical co ltd, in 2017 has announced results of phase ½ clinical trial of opdivo (nivolumab). This drug has shown to give better results to patients who are suffering from vulvar cancer.<\/p>\n

PDS Biotechnology Corporation, a biotechnological company is working on the development of new drug PDS0101 which is used for the treatment of vulvar cancer. In 2016, the company had submitted results obtained from phase I\/IIA clinical study of PDS0101. The study had shown a strong position for this drug which has given a superior disease-specific T-cell response.<\/p>\n

Qiagen, a provider of sample and assay technologies for molecular diagnostics, testing and pharmaceutical research. This company has introduce new in vitro method for detecting human papillomavirus which causes vulvar cancer.<\/p>\n

Novartis AG, a Swiss headquartered company has introduced Oncofocus®. Oncofocus® which is the oncology test used for detection of type of cancer and is considered as world’s most comprehensive precision oncology test which increases the chances of successful treatment.<\/p>\n

Merck& Co. one of the leading pharmaceutical and research company has introduced Gardasil. This vaccine is approved by FDA for the treatment of vaginal and vulvar cancer.<\/p>\n

Global Vulvar Cancer Market – Regional Analysis<\/strong><\/p>\n

On regional basis the global vulvar cancer market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. North America contribute the largest share in the market of vulvar cancer. Due to increasing prevalence of cancer in this region this market is expecting a swift growth. Europe is the second largest market followed by Asia Pacific. The outstanding development of healthcare sector in Asia Pacific region, it is responsible for the highest growth rate of this market in this region.<\/p>\n

Get Exclusive Discount @ <\/strong>https:\/\/www.marketresearchfuture.com\/check-discount\/1423<\/a><\/p>\n

About US:<\/strong><\/p>\n

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

Contact Us:<\/strong><\/p>\n

Market Research Future <\/p>\n

Office No. 528, Amanora Chambers<\/p>\n

Magarpatta Road, Hadapsar,<\/p>\n

Pune – 411028                        <\/p>\n

Maharashtra, India<\/p>\n

Phone: <\/strong>+1 646 845 9312<\/p>\n

Email:<\/strong> sales@marketresearchfuture.com<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/vulvar-cancer-market-1423<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Market Research Future” \u201cVulvar Cancer Market\u201d Complete Universal Study on MarketResearchFuture.com Overview of Key Players and their Strategic Profiling in the Market, Comprehensively Analyzing their Core Competencies, and Drawing a Competitive Landscape for the Market. Global Vulvar Cancer Market – … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-268653","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/268653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=268653"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/268653\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=268653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=268653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=268653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}